The board of directors of Nasdaq-listed company Anixa Biosciences has approved the purchase of Bitcoin as a reserve asset
Bitget2024/11/22 13:58
According to PR Newswire, Anixa Biosciences, Inc. (NASDAQ: ANIX), a Nasdaq-listed company in the United States, announced that its board of directors has approved the purchase of Bitcoin as a treasury reserve asset with the aim of diversifying the company's assets and enabling Anixa to benefit from the potential long-term value of digital assets. It is reported that Anixa is a clinical-stage biotechnology company focused on cancer treatment and prevention.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Locked for new tokens.
APR up to 10%. Always on, always get airdrop.
Lock now!
You may also like
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$104,160.1
+0.96%
Ethereum
ETH
$2,461.09
+0.93%
Tether USDt
USDT
$1
+0.01%
XRP
XRP
$2.34
-2.37%
BNB
BNB
$651.18
-0.02%
Solana
SOL
$170.28
-0.54%
USDC
USDC
$0.9999
-0.01%
Dogecoin
DOGE
$0.2271
+0.02%
Cardano
ADA
$0.7897
-1.41%
TRON
TRX
$0.2605
+0.57%
How to sell PI
Bitget lists PI – Buy or sell PI quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new Bitgetters!
Sign up now